Bharat Parenterals Ltd

NSE: BPLPHARMA · BSE: 541096 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,880.80
Market cap: ₹1,296 Cr
Revenue (annual): ₹345.4 Cr
Net profit (annual): ₹-8.19 Cr
P/E (TTM): -84.2×Sector 47.4×
Promoter holding: 67.20%+0.03% QoQ
FII holding: 0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Other Announcement 1 Management Change 1 Dividend 1 Capacity Expansion 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Aug 2026 15:39 IST BSE

Capacity Expansion

Bharat Parenterals Capacity Expansion: ₹300 Cr Investment

Bharat Parenterals is upgrading its subsidiary Varenyam Biolifesciences' Savli facility for biologics and biosimilars. This expansion involves a revised Phase 1 capital expenditure of ₹300 Crore.

Value: ₹300.0 Cr
Execution: Q2 2028

Read the filing ↗